Every Form 4 that Imax Corp (IMAX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IMAX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IMAX filings page.
IMAX Corporation reports that Chief Commercial Officer & EVP Giovanni M. Dolci acquired 2,578 restricted share units on September 15, 2026. The units vest in three installments, and each represents a contingent right to receive one common share. After the transaction, his aggregate remaining balances were 24,512 restricted share units and 41,027 common shares.
IMAX CORP (IMAX) reported that Chief Legal Officer and Senior Executive Vice President Robert D. Lister sold 22,500 common shares on September 10, 2026 in a sale characterized as an open market or private transaction at $51.5812 per share, with no Rule 10b5-1 plan reported.
After this sale, Mr. Lister holds 182,375 common shares directly and has 53,272 restricted share units outstanding, according to the footnote.
IMAX CORP (IMAX) officer Mark Welton, President IMAX Global Theatres, reported selling 30,000 common shares on 2026-08-25 in a sale classified as a “Sale in open market or private transaction” at an average price of $54.4736 per share. After this transaction, he directly holds 143,216 common shares and has remaining balances of 53,272 restricted share units, as disclosed in the footnote. The Rule 10b5‑1 checkbox is not marked as an affirmative trading plan.
IMAX CORP (IMAX) insider Kenneth Ian Weissman, Deputy GC, Corporate Secretary & CCO, reported a sale of 8,000 common shares on 2026-08-25 in an open-market or private transaction at a reported price of $54.5367 per share. Following this transaction, he held 28,205 common shares directly. A related footnote states that his aggregate remaining restricted share units and common share balances after this transaction are 11,253 restricted share units and 28,205 common shares, respectively.
IMAX CORP (IMAX) reported that Chief Financial Officer & EVP Natasha Fernandes sold 20,000 common shares on 2026-08-24 in an open market or private transaction at a price of $54.6277 per share. After this sale, she holds 35,596 common shares directly, and, according to a footnote, her aggregate remaining balances are 32,764 restricted share units and 35,596 common shares.
IMAX CORP (IMAX) reported an insider transaction by Pablo Calamera, CTO & EVP. On 2026-08-20, he completed an open-market sale of 15,000 common shares at a price of $52.4116 per share. Following this sale, he directly held 43,012 common shares, and his aggregate remaining outstanding restricted share units totaled 20,840.
IMAX CORP (IMAX) reported insider transactions by Chief Executive Officer Richard L. Gelfond involving option exercises and share sales executed under a Rule 10b5-1 trading plan dated May 19, 2026. On August 18 and 19, 2026, he converted stock options into a total of 356,757 common shares at an exercise price of $31.90 per share and sold the converted shares in open-market transactions. He also sold an additional 100,000 common shares on August 20, 2026.
Following these transactions, Mr. Gelfond’s aggregate remaining holdings are disclosed as 975,654 stock options, 231,562 restricted share units, and 665,002 common shares.
IMAX Corp senior vice president, controller and principal accounting officer Jose Aleksandr Zlatar reported an open-market sale of 500 common shares on August 6, 2026 at $49.90 per share. Following these transactions, he directly holds 583 common shares and 6,695 restricted share units.
IMAX Corporation director Darren D. Throop reported routine equity compensation activity involving restricted share units (RSUs) and related tax withholding. On June 11, 2026, 4,611 RSUs converted into 4,611 common shares, reflecting the vesting of a prior grant. To cover tax obligations on this vesting, 2,474 common shares were withheld by the company at a value of $42.12 per share rather than sold in the open market.
On the same date, Throop received a new grant of 4,611 RSUs in connection with his service on the IMAX board, each economically equivalent to one common share and described as vesting and converting on the grant date. After these transactions, the filing reports 40,655 IMAX common shares held directly and 4,611 RSUs outstanding.
IMAX Corporation director Michael MacMillan reported routine equity compensation activity involving restricted share units and related tax withholding. On June 11, 2026, 3,390 restricted share units converted into 3,390 common shares, each unit being economically equivalent to one common share.
To cover tax withholding obligations tied to this conversion, 1,849 common shares were withheld and disposed of. Following these transactions, MacMillan directly holds 39,569 common shares and 3,390 restricted share units, which were granted in connection with his service on the IMAX board and vest and convert on the grant date.
IMAX CORP director Eric A. Demirian reported compensation-related equity transactions. On June 11, 2026, restricted share units covering 3,390 units vested and converted into 3,390 common shares, each unit being economically equivalent to one common share.
To cover tax withholding obligations tied to this conversion, 1,842 common shares were withheld and disposed of. Demirian also received a new grant of 3,390 restricted share units in connection with his Board service. Following these transactions, he directly owns 38,641 common shares.
IMAX Corporation director Dana R. Settle reported equity-based compensation activity involving restricted share units (RSUs) and common shares. She exercised 3,390 restricted share units into 3,390 IMAX common shares, increasing her directly held common shares to 69,090.
On the same date, she received a new grant of 3,390 restricted share units in connection with her service on the IMAX board. Each restricted share unit is the economic equivalent of one IMAX common share and represents a contingent right to receive one common share upon vesting and conversion.
IMAX CORP director Jennifer L. Wong increased her equity stake through restricted share unit activity. On June 11, 2026, 3,390 restricted share units vested and converted into 3,390 common shares, reflecting compensation previously granted for her board service.
On the same date, she received a new grant of 3,390 restricted share units, each representing the economic equivalent of one common share and a contingent right to receive one common share. Following these transactions, she directly holds 22,582 common shares and 3,390 restricted share units. No open‑market purchases or sales were reported in this filing.
IMAX Corporation director Steve Pamon reported equity compensation activity rather than open-market trading. He received a grant of 3,390 restricted share units in connection with his Board service. Each unit is economically equivalent to one IMAX common share and represents a contingent right to receive a share.
On June 11, 2026, the restricted share units vested and converted into 3,390 common shares on the grant date. Following this conversion, Pamon directly held 35,515 IMAX common shares, up from an opening balance of 32,125 shares. The filing does not show any sales or gifts, only grants and conversions related to compensation.
IMAX CORP director Gail Berman reported equity compensation activity involving restricted share units and common shares. She received a grant of 3,390 restricted share units in connection with her membership on the IMAX Board of Directors. Each restricted share unit represents the economic equivalent of one common share.
On the grant date, 3,390 restricted share units vested and converted into 3,390 common shares. Following these transactions, Berman directly holds 22,582 common shares and 3,390 restricted share units, reflecting a routine combination of RSU grant and same‑day vesting into common shares as part of her director compensation.
IMAX Corp director David W. Leebron reported equity compensation activity rather than open‑market trading. He converted 3,390 restricted share units into 3,390 common shares, with each unit equal to one common share. On the same date he received a new grant of 3,390 restricted share units in connection with his Board membership. Following these transactions, he directly holds 131,083 common shares and indirectly holds 1,300 common shares through his spouse.
DOUGLAS KEVIN reported acquisition or exercise transactions in this Form 4 filing.
IMAX CORP director and 10% owner Kevin Douglas reported a grant of 3,390 shares of Common Stock through vested restricted stock units. The award was recorded at a price of $0.0000 per share and increased his direct ownership to 3,660,840 IMAX shares following the transaction.
The filing also lists significant additional indirect holdings in IMAX Common Stock held through various family trusts, including the Nonexempt Trust FBO Kevin G. Douglas, multiple Irrevocable Descendants' Trusts, Celtic Financial, LLC, and entities associated with James E. Douglas III. These entries reflect how Douglas and related parties hold shares across several trusts and entities rather than new open-market buying or selling.
IMAX CORP Chief Executive Officer Richard Gelfond reported an option exercise and related share sale. On April 27, 2026, he converted 8,943 stock options into common shares at $31.40 per share, then sold 8,943 common shares at an average price of $37.3269 per share.
The transactions were executed pursuant to a Rule 10b5-1 plan dated December 9, 2025, and sales under that plan are now complete. Following these transactions, Gelfond holds 765,002 common shares, with remaining outstanding option, restricted share unit and common share balances of 1,332,411 stock options, 231,562 restricted share units and 765,002 common shares, respectively.
IMAX CORP Chief Executive Officer Richard L. Gelfond exercised stock options and sold the resulting shares in pre-planned trades. On April 16–17, 2026, he converted a total of 75,919 stock options into common shares at $31.40 per share and executed open‑market sales of the same 75,919 common shares at roughly $37.05 per share, pursuant to a Rule 10b5‑1 plan dated December 9, 2025.
Following these transactions, Mr. Gelfond directly holds 765,002 common shares, with additional remaining awards of 1,341,354 outstanding stock options and 231,562 restricted share units. The options exercised were originally granted in 2016 and are scheduled to expire on June 7, 2026, so the activity reflects the use of nearing‑expiration options combined with a pre‑scheduled liquidity event.
IMAX CORP Chief Executive Officer Richard L. Gelfond exercised stock options and sold the resulting shares in a planned series of transactions. He converted options into 120,132 common shares at $31.40 per share under a Rule 10b5-1 trading plan dated December 9, 2025.
On April 13–15, 2026, he then sold the same 120,132 common shares in open-market trades, including sales at $37.1526, $37.0678 and $37.0707 per share. Following these transactions, he directly owns 765,002 common shares, with remaining outstanding option, restricted share unit and common share balances of 1,417,273 options, 231,562 restricted share units and 765,002 common shares.
IMAX CORP Chief Executive Officer Richard L. Gelfond converted stock options into 135,046 common shares at $31.40 per share and then sold the same 135,046 shares in open-market transactions at an average of $37.8158 per share, pursuant to a Rule 10b5-1 trading plan dated December 9, 2025.
Following these transactions, he directly holds 765,002 common shares and retains 1,537,045 outstanding stock options and 231,562 restricted share units, indicating a substantial remaining equity position in IMAX.
IMAX CORP Chief Executive Officer Richard L. Gelfond exercised stock options and sold the resulting common shares in pre-planned transactions. He converted a total of 25,024 stock options into common shares at an exercise price of $31.40 per share and sold the same 25,024 shares in open-market trades at prices of $40.0034 and $40.2621 per share.
These option exercises were made under a Rule 10b5-1 Plan dated December 9, 2025 and relate to options granted in 2016 that are set to expire on June 7, 2026. Following the transactions, Mr. Gelfond directly holds 765,002 common shares, with remaining outstanding option, restricted share unit and common share balances of 1,672,451, 231,562 and 765,002, respectively.
IMAX CORP executive Daniel Manwaring, CEO of IMAX China Holding, reported several stock-based compensation movements on March 7, 2026. He exercised vested restricted share units, converting 7,409 and 4,666 units into the same number of common shares. He also received a new award of 5,072 restricted share units, each economically equivalent to one common share.
To cover tax obligations tied to these deliveries, the company withheld 4,790 common shares at $40.80 per share, a non‑market, tax-withholding disposition rather than an open-market sale. After these transactions, Manwaring holds 12,363 common shares and 21,816 restricted share units directly.
IMAX CORP director and 10% owner Kevin Douglas–related entities reported sizable open-market sales of IMAX common stock. On March 16, 2026, accounts and trusts associated with Douglas sold a combined 568,000 shares at $37.82 per share.
After these transactions, Douglas and related entities still hold large positions, including 3,657,450 shares in a direct and joint account and additional shares through family trusts and Celtic Financial LLC. A footnote states the shares sold represent about 6.5% of his overall IMAX holdings and that his last sale of IMAX shares occurred in 2015.
IMAX CORP Chief Executive Officer Richard L. Gelfond converted stock options into 121,220 common shares at an exercise price of $31.40 per share and on the same day sold 121,220 common shares at an average price of $40.0993 per share.
The conversion and sale were carried out under a pre-arranged Rule 10b5-1 trading plan. After these transactions, he directly holds 765,002 common shares, along with remaining outstanding options over 1,697,475 shares and 231,562 restricted share units, indicating he retains a substantial equity stake.
IMAX CORP Chief Executive Officer Richard L. Gelfond reported compensation-related equity transactions in common shares. He acquired 196,964 common shares upon conversion of vested performance stock units tied to EBITDA performance conditions and 91,768 common shares from units tied to TSR performance conditions, both originally granted on January 2, 2023. To satisfy tax withholding obligations on these conversions, 159,670 common shares were withheld at a price of $40.80 per share. Following these transactions, he directly holds 765,002 common shares, with additional remaining outstanding option, restricted share unit and common share balances of 1,818,695 options, 231,562 restricted share units and 765,002 common shares, respectively.
IMAX Corporation’s Chief Financial Officer and EVP Natasha Fernandes reported multiple equity compensation transactions. She exercised and converted restricted and performance stock units into a total of 20,496 common shares at a conversion price of $0.00 per share.
To cover tax obligations on these deliveries, the company withheld 28,044 common shares at a value of $40.80 per share, recorded as tax-withholding dispositions rather than open-market sales. She also received new grants of 13,526 restricted share units and 32, - sorry - wait
IMAX Corporation Chief People Officer & EVP Michele Golden reported several equity compensation transactions involving restricted share units, performance stock units, and common shares on March 7, 2026. She converted 24,423 restricted and performance units into common shares.
IMAX withheld 20,059 common shares at $40.80 to cover tax obligations related to these conversions, which are not open-market sales. Golden also received new grants of 10,144 restricted share units and 16,420 common shares. Following these transactions, she holds 37,759 common shares and 29,852 restricted share units.
IMAX Corporation CTO & EVP Pablo Calamera reported equity compensation activity involving restricted and performance share units. He exercised or converted 18,786 restricted and performance share units into common shares and received additional share-based awards.
To cover tax obligations, 15,733 common shares were withheld by IMAX at $40.80 per share, which is a non-market, tax-withholding disposition rather than an open-market sale. Following these transactions, Calamera directly holds 58,012 common shares and 20,840 restricted share units, reflecting a net increase in his IMAX equity stake.
IMAX CORP senior executive Jose Aleksandr Zlatar reported routine equity compensation activity. He exercised restricted share units to acquire 1,000 and 1,333 common shares on March 7, 2026, converting previously granted units into stock at a stated price of $0.00 per share.
On the same date, IMAX withheld 1,250 common shares at $40.80 per share to cover tax obligations related to the RSU conversions, which is a non-market disposition rather than an open-market sale. Zlatar also received a new grant of 2,028 restricted share units, each economically equivalent to one common share.
Following these transactions, he directly holds 1,083 common shares and 6,695 restricted share units. The RSUs vest in scheduled installments between 2026 and 2029, reflecting ongoing, structured compensation rather than discretionary trading in IMAX stock.
IMAX CORP Chief Content Officer Jonathan Fischer reported compensation-related equity activity involving restricted share units and common shares. On March 7, 2026, 5,333 restricted share units converted into 5,333 common shares, and IMAX withheld 1,914 common shares at $40.80 per share to cover tax obligations.
Fischer also received a new grant of 10,821 restricted share units. Following these transactions, he holds 3,419 common shares and 21,488 restricted share units in total. These actions reflect equity vesting, grants, and tax withholding rather than open-market buying or selling.
IMAX Corporation executive Daniel Manwaring, CEO of IMAX China Holding, reported compensation-related equity activity involving restricted share units and common shares on March 7, 2026. He exercised restricted share units that converted into 12,075 common shares, reflecting the vesting of prior equity awards.
In connection with this conversion, 5,435 common shares were withheld by IMAX Corporation at $40.80 per share to satisfy tax withholding obligations, a non-market disposition. Following these transactions, Manwaring directly holds 11,718 common shares and 21,816 restricted share units, with future RSU tranches scheduled to vest annually from 2027 through 2029.
IMAX CORP President IMAX Global Theatres Mark Welton reported multiple equity compensation transactions in common shares and restricted share units. On March 7, 2026 he received grants and conversions of restricted share units and performance stock units into common shares, with no cash purchase or open-market sale activity.
IMAX Corporation withheld 51,720 common shares at $40.80 per share to satisfy tax obligations tied to these vesting and conversion events, which are coded as tax-withholding dispositions. According to the footnotes, following these transactions Welton holds 173,216 common shares and 53,272 restricted share units.
IMAX Corporation’s Deputy General Counsel, Corporate Secretary and Chief Compliance Officer Kenneth Ian Weissman reported routine equity compensation activity. He exercised and converted restricted and performance share units into 9,420 common shares, reflecting the vesting of prior awards. To cover tax obligations on these deliveries, IMAX withheld 5,681 common shares at a price of $40.80 per share, which is recorded as tax-withholding dispositions rather than open-market sales. Weissman also received new grants of restricted share units and common shares as compensation. Following these transactions, he holds 36,205 common shares and 11,253 restricted share units, indicating a continued significant equity stake aligned with shareholders.
IMAX Chief Commercial Officer & EVP Giovanni M. Dolci reported several equity compensation events on March 7, 2026. He converted a total of 10,460 restricted share units and performance stock units into common shares, received additional restricted share unit and common share awards, and had 7,123 common shares withheld at $40.80 per share to cover tax obligations. Following these transactions, he holds 41,027 common shares directly and 21,934 remaining restricted share units.
IMAX Corporation’s Chief Legal & Sr Exec VP Robert D. Lister reported multiple equity compensation events. On March 7, 2026, vested restricted share units and performance stock units were converted into 36,950 common shares, reflecting previously granted awards.
To cover tax obligations on these conversions, IMAX withheld 51,159 common shares at $40.80 per share, which is recorded as a tax-withholding disposition rather than an open-market sale. Lister also received new equity awards, including 19,613 restricted share units and additional common share grants. After these transactions, he holds 204,875 common shares and 53,272 restricted share units directly.
IMAX CORP Chief Marketing Officer Anne Globe reported several equity compensation transactions dated March 7, 2026. She converted 12,225 and 5,500 vested restricted share units into the same number of common shares, reflecting routine settlement of prior awards. She also received a new grant of 12,512 restricted share units, each economically equivalent to one common share. To cover tax obligations related to the share delivery, IMAX Corporation withheld 6,904 common shares at $40.80 per share rather than selling them in the market. Following these transactions, Globe holds 18,574 common shares and 35,739 restricted share units in total.
IMAX Corporation chief executive officer and director Richard L. Gelfond reported multiple equity transactions on January 2, 2026 involving IMAX common shares and restricted share units. Vested restricted share units were converted into common shares at an exercise price of $0.00, and a portion of those shares was withheld at a price of $36.02 per share to cover related tax obligations. Following these transactions, Mr. Gelfond beneficially owns 635,940 IMAX common shares directly, along with outstanding equity awards consisting of 1,818,695 options and 231,562 restricted share units. The restricted share units are scheduled to vest in installments through January 2, 2029, each unit representing the right to receive one IMAX common share.
IMAX Corp officer Mark Welton, President IMAX Global Theatres, reported a sale of 25,000 common shares on 12/15/2025 at $39.28 per share. The sale was made pursuant to a Rule 10b5-1 Plan dated September 15, 2025.
After this transaction, he beneficially owns 128,323 common shares, and his remaining restricted share unit balance is 70,609.
IMAX Corporation executive Robert D. Lister, the Chief Legal Officer and Senior Executive Vice President, reported a charitable transfer of company stock. On December 11, 2025, he gifted 2,000 common shares of IMAX Corporation to a donor-advised fund, with the shares to be used for charitable purposes. The Form 4 shows the transaction at a price of $0.00, reflecting that this was a gift rather than a sale.
Following this transaction, Mr. Lister beneficially owns 159,421 common shares and holds 70,609 restricted share units. The filing notes that the timing of the gift relates to changes in tax regulations affecting charitable donations that take effect on January 1, 2026.
IMAX Corporation’s Chief Financial Officer and EVP, Natasha Fernandes, reported an options exercise and share sale involving the company’s common shares. On 11/24/2025, she exercised 2,652 stock options with an exercise price of $22.49 per share, converting them into 2,652 common shares. That same day, she sold 2,652 common shares at an average price of $36.1479 per share, returning her directly held common share balance to 31,257 shares.
The options were originally granted in 2019 and are scheduled to expire on March 7, 2026, having vested in four annual installments between 2020 and 2023. Following these transactions, Ms. Fernandes’ aggregate remaining outstanding restricted share unit balance is 39,734, and her common share balance remains 31,257, reflecting a same-day exercise-and-sale transaction structure.
IMAX Corp reported a Form 4 for CEO and Director Richard L. Gelfond, who gifted 40,000 common shares on 11/10/2025 (transaction code G) to a donor‑advised fund for charitable purposes. After the transfer, he beneficially owns 564,599 common shares directly.
The filing also lists his outstanding awards following the transaction: 1,818,695 options and 294,433 restricted share units. It states the timing relates to changes in tax regulations taking effect on 01/01/2026.
IMAX (IMAX) executive Mark Welton reported an option exercise and share sale. On 11/10/2025, he exercised stock options into 49,504 common shares at $22.49 per share and sold 49,504 common shares at a price of $35.228.
Following these transactions, he beneficially owns 153,323 common shares directly. The filing notes 70,609 restricted share units outstanding after these transactions and that the options exercised were issued in 2019 and set to expire on March 7, 2026.
IMAX Chief Commercial Officer Giovanni M. Dolci reported an option exercise and same‑day sale. On 11/10/2025, he exercised 6,188 stock options at $22.49 and sold 6,188 common shares at a weighted average price of $34.2452, leaving 33,000 common shares held directly.
The options were issued in 2019 and are set to expire on March 7, 2026. The filing notes remaining restricted share units of 21,574 following these transactions.
IMAX (IMAX) reported an insider transaction by CTO & EVP Pablo Calamera. On 11/10/2025, he executed a sale coded “S” of 20,586 common shares at a price of $34.2255 per share. Following the sale, his beneficially owned common shares total 40,886, held directly.
The filing also notes remaining restricted share units of 32,863 after the reported transactions. This Form 4 reflects a routine insider share sale and updated holdings.
IMAX Corp (IMAX): Form 4 insider activity. On 11/07/2025, Chief Legal Officer and Sr. EVP Robert D. Lister exercised stock options to acquire 50,143 common shares at $22.49 pursuant to a Rule 10b5-1 plan dated June 11, 2025, then sold 50,143 shares at $34.6652 the same day. After these transactions, he directly beneficially owned 161,421 common shares. The filing notes remaining restricted share units of 70,609. The options were issued in 2019 and set to expire on March 7, 2026, and the derivative balance following these transactions is listed as 0.